Keratinocyte growth factor induces vascular endothelial growth factor - A expression in colorectal cancer cells

International Journal of Oncology

Volumn 34, Issue 2, 2009, Pages 355-360

  Narita, Kosuke ^a   Fujii, Takenori ^a   Ishiwata, Toshiyuki ^a   Yamamoto, Tetsushi ^a   Kawamoto, Yoko ^a   Kawahara, Kiyoko ^a   Nakazawa, Nando ^a   Naito, Zenya ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Colorectal cancer; Fibroblast growth factor 2; Hepatocyte growth factor; Keratinocyte growth factor; Tumor angiogenesis; Vascular endothelial growth factor A

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; RECOMBINANT KERATINOCYTE GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN A;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; TUMOR VASCULARIZATION;

APOPTOSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 7; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, PROSTAGLANDIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64549087241     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000158     Document Type: Article

References (30)

1. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802-806, 1989.
2. Finch PW, Rubin JS, Miki T, Ron D and Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245: 752-755, 1989.
3. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, Taylor WG, Fortney E, Sakata H, Finch PW, et al: Keratinocyte growth factor. Cell Biol Int 19: 399-411, 1995.
4. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM and Aaronson SA: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89: 246-250, 1992.
5. Ornitz DM and Itoh N: Fibroblast growth factors. Genome Biol 2: Reviews S3005, 2001.
6. Putnins EE, Firth JD, Lohachitranont A, Uitto VJ and Larjava H: Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin. Cell Adhes Commun 7: 211-221, 1999.
7. Gillis P, Savla U, Volpert OV, Jimenez B, Waters CM, Panos RJ and Bouck NP: Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 112: 2049-2057, 1999.
8. Yoshino M, Ishiwata T, Watanabe M, Matsunobu T, Komine O, Ono Y, Yamamoto T, Fujii T, Matsumoto K, Tokunaga A and Naito Z: Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. Int J Oncol 31: 721-728, 2007.
9. Ishikawa A, Kudo M, Nakazawa N, Onda M, Ishiwata T, Takeshita T and Naito Z: Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones. Int J Oncol 32: 565-574, 2008.
10. Cho K, Ishiwata T, Uchida E, Nakazawa N, Korc M, Naito Z and Tajiri T: Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol 170: 1964-1974, 2007.
11. Watanabe M, Ishiwata T, Nishigai K, Moriyama Y and Asano G: Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol Int 50: 363-372, 2000.
12. Finch PW and Rubin JS: Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98: 812-824, 2006.
13. Matsunobu T, Ishiwata T, Yoshino M, Watanabe M, Kudo M, Matsumoto K, Tokunaga A, Tajiri T and Naito Z: Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer. Int J Oncol 28: 307-314, 2006.
14. Yoshino M, Ishiwata T, Watanabe M, Komine O, Shibuya T, Tokunaga A and Naito Z: Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer. Oncol Rep 13: 247-252, 2005.
15. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S and Distler O: Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47: 149-161, 2003.
16. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
17. Gospodarowicz D: Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249: 123-127, 1974.
18. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, Matsumura M, Kaneko N, Terano A, Nakamura T, et al: Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 95: 1994-2003, 1995.
19. Igawa T, Kanda S, Kanetake H, Saitoh Y, Ichihara A, Tomita Y and Nakamura T: Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 174: 831-838, 1991.
20. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R and Rusnati M: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178, 2005.
21. Hansen S, Grabau DA, Rose C, Bak M and Sorensen FB: Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 78: 1563-1573, 1998.
22. Schoell WM, Pieber D, Reich O, Lahousen M, Janicek M, Guecer F and Winter R: Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer 80: 2257-2262, 1997.
23. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y and Sugimachi K: Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 77: 1722-1728, 1996.
24. Kudo M, Ishiwata T, Nakazawa N, Kawahara K, Fujii T, Teduka K and Naito Z: Keratinocyte growth factor-transfection-stimulated adhesion of colorectal cancer cells to extracellular matrices. Exp Mol Pathol 83: 443-452, 2007.
25. Oelmann E, Haghgu S, Kulimova E, Mesters RM, Kienast J, Herbst H, Schmitmann C, Kolkmeyer A, Serve H and Berdel WE: Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro. Int J Oncol 25: 1001-1012, 2004.
26. Zang XP and Pento JT: Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis 18: 573-580, 2000.
27. Shin EY, Lee BH, Yang JH, Shin KS, Lee GK, Yun HY, Song YJ, Park SC and Kim EG: Up-regulation and coexpression of fibroblast growth factor receptors in human gastric cancer. J Cancer Res Clin Oncol 126: 519-528, 2000.
28. Niu J, Chang Z, Peng B, Xia Q, Lu W, Huang P, Tsao MS and Chiao PJ: Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors. J Biol Chem 282: 6001-6011, 2007.
29. McDonnell AM and Lenz KL: Palifermin: role in the prevention of chemotherapy - and radiation-induced mucositis. Ann Pharmacother 41: 86-94, 2007.
30. Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, Cesano A, Gayko U, Chen MG and Clarke S: Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 24: 5194-5200, 2006.